This website uses cookies to improve your experience. Continue if you are OK with this or read more in our privacy policy. 

GSK announces £500m UK investment after patent box confirmed


Pharmaceutical maker GlaxoSmithKline (GSK) is to invest more than £500 million in UK manufacturing following the chancellor’s announcement of tax relief for UK and European patent profits.

GSK, investment, patent box


Payment types accepted